GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dbv Technologies DBV.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

1.96

+8.89%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$4.2m

FY2015FY2024

Net income

−$114.1m

FY2015FY2024

Free cash flow

−$105.5m

FY2015FY2024

Shareholders' equity

$27.4m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$4.2m$15.7m$4.8m$5.7m$11.3m$14.7m$15.3m$12.6m$9.6m$6.2m
Gross profit$3.5m$15.1m$4.1m$5.2m$11.0m$13.6m$13.7m$10.9m$8.4m$6.0m
Research and development$88.8m$71.6m$61.1m$58.0m$81.1m$107.9m$107.6m$106.4m$80.0m$32.1m
Operating income−$116.5m−$76.3m−$96.2m−$99.2m−$135.0m−$170.3m−$175.4m−$153.0m−$122.5m−$45.5m
Net income−$114.1m−$72.7m−$96.0m−$98.1m−$159.7m−$172.5m−$175.3m−$155.9m−$120.9m−$44.7m
Diluted earnings per share-1.18-0.76-1.24-1.79-2.95-4.66-6.06-6.30-4.94-2.08

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$65.5m$183.0m$246.5m$146.3m$272.0m$271.3m$181.3m$187.7m$303.4m$343.3m
Cash and short-term investments$32.5m$141.4m$209.2m$77.3m$196.4m$193.3m$129.6m$145.5m$270.7m$323.4m
Total liabilities$38.2m$42.7m$52.0m$47.3m$66.6m$78.5m$53.3m$50.5m$47.1m$21.2m
Debt$7.0m$5.7m$3.0m$10.2m$14.2m$25.7m————
Shareholders' equity$27.4m$140.3m$194.5m$99.0m$205.4m$192.7m$128.0m$137.1m$256.3m$322.1m
Shares outstanding97m95m77m55m54m37m29m25m24m22m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$103.2m−$77.6m−$51.4m−$104.1m−$160.9m−$143.9m−$144.2m−$120.6m−$62.8m−$26.8m
Capital spending−$2.3m−$677,000−$754,000−$918,000−$2.8m−$5.6m−$5.0m−$8.0m−$8.7m−$4.5m
Free cash flow−$105.5m−$78.3m−$52.2m−$105.0m−$163.7m−$149.5m−$149.2m−$128.6m−$71.5m−$31.3m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022
Revenue$2.2m$1.6m$2.6m$11.2m$2.4m$4.5m$2.2m$770,000
Gross profit————$2.4m—$2.2m—
Operating income−$67.6m−$54.1m−$62.4m−$30.0m−$18.3m−$46.0m−$21.2m−$55.9m
Net income−$69.0m−$53.5m−$60.6m−$28.0m−$16.7m−$45.0m−$20.6m−$56.5m
Diluted earnings per share-0.58-0.55-0.63-0.29-0.17-0.48-0.22-0.60
Total assets$143.2m$65.5m$114.1m$183.0m$189.8m$217.0m$232.9m$246.5m
Cash and short-term investments$103.2m$32.5m$66.2m$141.4m$149.1m$174.0m$192.3m$209.2m
Debt$6.7m$6.3m$6.8m$4.5m—$190,000—$1.1m
Shareholders' equity$86.2m$27.4m$79.2m$140.0m$144.0m$164.0m$179.1m$194.5m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin-325.4%100.0%100.0%19.0%-62.5%-166.9%———
Operating margin-2819.7%-2808.7%-479.2%-385.5%-1560.0%-1313.0%———
Net margin-2713.6%-2744.4%-462.4%-384.0%-1713.5%-1735.3%———
Return on equity-90.6%-415.9%-51.9%-49.5%-98.5%-77.6%———
Return on assets-65.4%-173.5%-39.7%-39.1%-66.7%-58.6%———
Free cash flow yield-37.2%-60.2%-46.6%-33.2%-110.7%-168.4%———
Revenue growth35.8%-73.6%-37.3%339.2%-49.4%-23.3%———
Earnings growth34.3%56.6%-24.5%-1.6%-50.0%0.2%———
Current ratio3.67x1.43x4.23x7.09x2.46x3.93x———
Debt to equity0.02x0.02x0.01x0.05x0.03x0.03x———
Equity ratio72.2%41.7%76.6%78.9%67.7%75.5%———
Interest coverage———-226.30x-152.53x-166.74x-90.78x-368.40x-32.84x
R&D as a share of sales1972.1%2152.3%382.9%301.2%1232.2%1105.1%———
Buybacks as a share of market value-99.1%-0.1%-2.3%-70.9%-0.2%0.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.1%-22.4%-1.4%
Operating income5.5%-7.3%16.8%
Net income5.2%-7.9%16.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin93.2%91.3%92.9%91.5%
Operating margin-969.8%-1275.5%-1229.2%-1158.4%
Net margin-939.9%-1251.7%-1263.9%-1176.8%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020
Price to earnings-0.6-2.8-3.0-2.0-1.1
Price to sales17.313.159.034.515.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.